Join to View Full Profile
830 Harrison AveMoakley, 3rd FloorBoston, MA 02118
Phone+1 617-638-6428
Fax+1 617-638-5756
Are you Dr. Steinberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Martin Steinberg, MD is a hematologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is a Professor at Boston University School of Medicine.
Education & Training
Tufts Medical CenterResidency, Internal Medicine, 1966 - 1968
NYU Grossman School of MedicineInternship, Transitional Year, 1962 - 1963
Tufts University School of MedicineClass of 1962
Certifications & Licensure
MA State Medical License 1965 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 1 citationsCRISPR-based gene therapy for the induction of fetal hemoglobin in sickle cell disease.Meghann McManus, Haydar Frangoul, Martin H Steinberg
Expert Review of Hematology. 2024-12-01 - 2 citationsPGC-1α agonism induces fetal hemoglobin and exerts antisickling effects in sickle cell disease.Yanan Sun, Hajar Benmhammed, Salam Al Abdullatif, Alawi Habara, Eric Fu
Science Advances. 2024-08-02 - Catechol-O-methyltransferase gene (COMT) is associated with neurocognitive functioning in patients with sickle cell disease.Andrew M Heitzer, Sara R Rashkin, Ana Trpchevska, Jennifer N Longoria, Evadnie Rampersaud
Current Research in Translational Medicine. 2024-06-01
Press Mentions
What if a CRISPR Cure Isn’t Such an Easy Choice?November 9th, 2023- FDA Approves Two Gene Therapies for Sickle Cell, Including First CRISPR-Based MedicineDecember 12th, 2023
- FDA Weighs Gene-Editing Treatments’ Curative Possibilities Against Potential RisksDecember 12th, 2023
